Health Canada’s acceptance of the submission follows that of the Ministry of Health, Labour and Welfare (WHLW) in Japan and approval by the US Food and Drug Administration (FDA) and… Read More
EP-104IAR demonstrates trends to reduction in joint inflammation and improvement in cartilage quality and morphology compared to placebo VICTORIA, BC – Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (Nasdaq:LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it submitted its much-anticipated Investigational New Drug (“IND”) application… Read More
GARCHING / MUNICH, DE & VANCOUVER, BC – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Alpha-9 Oncology (Alpha-9), a clinical stage biotechnology company developing differentiated and highly targeted radiopharmaceuticals, announced… Read More
Cancer patients and their families will benefit from more access to life-saving cancer diagnostics as new equipment and research expand access to PET/CT scans and innovative cancer treatments throughout the… Read More
